Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
detroit blog main
4
×
detroit top stories
national blog main
national top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
fda
indiana blog main
indiana top stories
life sciences
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
calcitonin gene-related peptide
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
migraine research foundation
national
teva pharmaceutical
aimmune therapeutics
alder biopharmaceutical
What
approval
4
×
fda
4
×
developed
drug
new
won
class
migraine
oral
agency
aimmune
allergy
amgen
ann
announced
approved
arbor
arguments
awarded
based
big
candidates
capital
commercialized
companies
competitors
decades
drugs
eye
fifth
friday
gets
head
immunotherapy
late
make
medical
medicines
meeting
michigan
Language
unset
Current search:
approval
×
fda
×
" detroit blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines